Aptar Pharma is an Illinois-based CDMO with a legacy dating back to its founding in 1946. The company specializes in drug delivery systems and provides sterile fill/finish services, leveraging cutting-edge technology to produce injectable, nasal, and pulmonary drug formulations. Aptar's comprehensive capabilities include formulation development, clinical trial material production, and scalable commercial manufacturing.